Assembly Biosciences, Inc. (ASMB)
NASDAQ: ASMB · Real-Time Price · USD
26.40
-0.60 (-2.22%)
Apr 29, 2026, 11:53 AM EDT - Market open
Assembly Biosciences Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | 58.45 | 38.34 | 19.84 | 52.42 | 45.63 | Upgrade
|
| Short-Term Investments | 189.66 | 73.74 | 110.41 | 39.19 | 101 | Upgrade
|
| Cash & Short-Term Investments | 248.11 | 112.08 | 130.25 | 91.61 | 146.63 | Upgrade
|
| Cash Growth | 121.37% | -13.95% | 42.18% | -37.52% | -32.25% | Upgrade
|
| Accounts Receivable | 0.97 | - | 0.04 | 0.94 | 0.34 | Upgrade
|
| Other Receivables | 1.5 | 0.4 | 0.3 | 0.3 | - | Upgrade
|
| Receivables | 2.47 | 0.4 | 0.34 | 1.24 | 0.34 | Upgrade
|
| Prepaid Expenses | 3.97 | 3.02 | 3.2 | 4.11 | 7.24 | Upgrade
|
| Total Current Assets | 254.55 | 115.5 | 133.79 | 96.97 | 154.2 | Upgrade
|
| Property, Plant & Equipment | 2.73 | 3.35 | 2.72 | 3.94 | 7.18 | Upgrade
|
| Long-Term Investments | - | - | - | - | 27.97 | Upgrade
|
| Long-Term Deferred Charges | - | - | - | 0.2 | 0.2 | Upgrade
|
| Other Long-Term Assets | 0.31 | 0.31 | 0.31 | 0.69 | 1.5 | Upgrade
|
| Total Assets | 257.59 | 119.17 | 136.82 | 101.79 | 191.06 | Upgrade
|
| Accounts Payable | 1.17 | 0.59 | 0.46 | 2.49 | 2.66 | Upgrade
|
| Accrued Expenses | 10.14 | 9.14 | 6.63 | 9.84 | 10.26 | Upgrade
|
| Current Portion of Leases | 0.57 | 0.46 | 1.22 | 3.36 | 3.15 | Upgrade
|
| Current Unearned Revenue | 36.9 | 37.62 | 30.92 | - | - | Upgrade
|
| Other Current Liabilities | - | - | - | 0.6 | - | Upgrade
|
| Total Current Liabilities | 48.78 | 47.8 | 39.23 | 16.3 | 16.07 | Upgrade
|
| Long-Term Leases | 2.06 | 2.63 | 1.12 | 0.1 | 3.33 | Upgrade
|
| Long-Term Unearned Revenue | - | 35.38 | 55.38 | 2.73 | 2.73 | Upgrade
|
| Total Liabilities | 50.84 | 85.81 | 95.73 | 19.13 | 22.13 | Upgrade
|
| Common Stock | 0.02 | 0.01 | 0.01 | 0 | 0.05 | Upgrade
|
| Additional Paid-In Capital | 1,039 | 859.49 | 826.92 | 807.98 | 800.73 | Upgrade
|
| Retained Earnings | -832.05 | -825.93 | -785.75 | -724.52 | -631.43 | Upgrade
|
| Comprehensive Income & Other | -0.04 | -0.21 | -0.08 | -0.8 | -0.42 | Upgrade
|
| Shareholders' Equity | 206.75 | 33.36 | 41.1 | 82.66 | 168.93 | Upgrade
|
| Total Liabilities & Equity | 257.59 | 119.17 | 136.82 | 101.79 | 191.06 | Upgrade
|
| Total Debt | 2.63 | 3.09 | 2.34 | 3.47 | 6.48 | Upgrade
|
| Net Cash (Debt) | 245.48 | 108.99 | 127.91 | 88.15 | 168.12 | Upgrade
|
| Net Cash Growth | 125.23% | -14.79% | 45.11% | -47.57% | -18.50% | Upgrade
|
| Net Cash Per Share | 21.90 | 18.15 | 27.94 | 21.85 | 46.61 | Upgrade
|
| Filing Date Shares Outstanding | 15.86 | 7.5 | 5.48 | 4.33 | 4.01 | Upgrade
|
| Total Common Shares Outstanding | 15.86 | 7.46 | 5.48 | 4.07 | 4.01 | Upgrade
|
| Working Capital | 205.77 | 67.7 | 94.56 | 80.67 | 138.13 | Upgrade
|
| Book Value Per Share | 13.04 | 4.47 | 7.50 | 20.29 | 42.13 | Upgrade
|
| Tangible Book Value | 206.75 | 33.36 | 41.1 | 82.66 | 168.93 | Upgrade
|
| Tangible Book Value Per Share | 13.04 | 4.47 | 7.50 | 20.29 | 42.13 | Upgrade
|
| Machinery | - | - | - | 0.8 | 0.72 | Upgrade
|
| Leasehold Improvements | - | - | - | 1.63 | 1.63 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.